Nine autochthonous cases of Toscana virus infection in France, 2022–2024: a clinical and virological overview

This study confirms the continued circulation of Toscana virus (TOSV) lineage B in France, with nine laboratory-confirmed autochthonous neuroinvasive cases identified between 2022 and 2024. All patients presented with central nervous system symptoms, predominantly during summer months, and most were confirmed by RT-qPCR (quantitative reverse transcription polymerase chain reaction) on cerebrospinal fluid. Phylogenetic analysis revealed close similarity to previously circulating French strains, supporting long-term local transmission. One case in eastern France raises concern for possible geographic expansion. These findings underscore the need for sustained surveillance and preventive measures in endemic regions, particularly for travellers and clinicians encountering summer-onset neurological syndromes.

Authors

Institutions

Publication Details

Journal
Journal of Travel Medicine
Published
2025-06-20
DOI
https://doi.org/10.1093/jtm/taaf057
Primary Topic
Viral Infections and Vectors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nine autochthonous cases of Toscana virus infection in France, 2022–2024: a clinical and virological overview

Gilda Grard, Rémi N. Charrel, Laura Pezzı, S. Bayle et al.
Journal of Travel Medicine
Viral Infections and Vectors
article

Nine autochthonous cases of Toscana virus infection in France, 2022–2024: a clinical and virological overview

Gilda Grard, Rémi N. Charrel, Laura Pezzı, S. Bayle, Guillaume André Durand, Läétitia Ninove, Antoine Nougaırède, Xavier Nicolas de Lamballerie, Raphaëlle Klitting, Léa Lucıanı, Nazlı Ayhan, Nadim Cassir, Julie Allemand, Anne Darmon, A. Chollet, Elif Kurum, Fabrice Edorh, Jean Sélim Drıouıch
article en

Abstract

This study confirms the continued circulation of Toscana virus (TOSV) lineage B in France, with nine laboratory-confirmed autochthonous neuroinvasive cases identified between 2022 and 2024. All patients presented with central nervous system symptoms, predominantly during summer months, and most were confirmed by RT-qPCR (quantitative reverse transcription polymerase chain reaction) on cerebrospinal fluid. Phylogenetic analysis revealed close similarity to previously circulating French strains, supporting long-term local transmission. One case in eastern France raises concern for possible geographic expansion. These findings underscore the need for sustained surveillance and preventive measures in endemic regions, particularly for travellers and clinicians encountering summer-onset neurological syndromes.

Journal of Travel MedicineVol. 32(6)
Inserm (FR), Aix-Marseille Université (FR), Olea Medical (France) (FR), Assistance Publique Hôpitaux de Marseille (FR), Hydrogen Fuel Cells and Electro-Mobility in European Regions (BE), Laboratoire Informatique d'Avignon (FR), Centre Hospitalier Edmond Garcin (FR)
Aix-Marseille Université, UK Research and Innovation, European Commission
Good health and well-being
Openalex Percentile: Top 81%
Viral Infections and Vectors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.